!" # $% $&"'(!# ) ( $*" + , - ./%' 0
!%
1 - 2" 3 4
3 567 89 : 8;
<
= !"
4>9?
@
!2A # B 3C !67'* D 3E F A 3 !2A # C # '(&#' 3
4G
$&H ( 3 94?99 Email: [email protected]
I = $= "
= &%' J
' $K 5 = + L%' # $= I
B" # D M/
C &HN # C &H C & ' O
P )' HI' -( Q 34
$R'( ( O (
4*
3 A (25 &
38
L= # F5 &
3>
$R F F -( 2O &
3>
S % -( / &
T
%' U
& V
"
$ (" '
# M W I -(M/%' 3
# M W I + ! (O' $ ' 'XV - ./%' 3
= & 'Y
3 W I # M -(M/%'
# M W I 3 + ! (O' $ ' 'XV - ./%'
" = = & 'Z
$ C' ![ $M" + , - ./%' 3$&"'(!# ) \ \5[ & &H%' "'(!# -(M/%' 3
& 'T
C' ![ $M" + , - ./%' 3$&"'(!# ) \ \5[ & &H%' "'(!# -(M/%' 3$ " =
-( MN
X ]
% / X' $^Q#
3
% 2% X' $/O I = X '( +(, #
1&H = &6 _ A 3$M
' -(" _ ' A P
`
7 [ # $ X'
!# C X a% ! "'(
/ X' $/O = 0 2&O' '
b (%'
' 3
O B" ' = B 2M[ ! $K 5 =
<
=
@AFP
$ ! /
"
`
_ '
]
= C 2 ) 7 # c='
/= ( = [ d # C &HN # C &H C & ' $K 5 AFP
0 6 ' = $
(" + L%'
`
3 O B" ' = !
84
- V e2 0 b= )( 2 # c=' # D M/ C' 2 # X' f ( % 2%
$I
3L20B RD Hep-2
& A ' g $# =X ' (
`
3$K 5 = !
9h 1&H X' % 2%
$% & 2 # !i" P 6 [
) 7 # ![
_ X' - 6& ' # 31 \&iH 3j k[
j k[
a#
<
Pellet
@
& = k[ _ Two-phase
3
= &%' -
$ # l
("
`
& = ] X' TG m
?>
(7
% 2%
X' $= I J = &%' 3 P
G>
m 8;
(7
I =
n
" '( cH ' (
` c o2
?8 m G
(7
% 2%
cH ' I = ' ' f (
89 m 4T (7
# $= I J = &%' ' ' (%
`
% 2% X'
I = f (
p [ 8
% 2% X'
p [ I = P
4 (/% X '(
`
L &%
A ] [ c=' = &%
q
= $K 5 = 57 # ( =
$ C &HN # C &H C & ' 0 6 ' = $ /= I (" #
`
( C AW'
] 3 O B"
3 = &%'
$= I J = &%' 3 I =
I \ =
] 8T m
? m 9T : I \ _ =l ]
48 m T m 9?
n P C' M2 C &HN # C &H O B" = =
m 84
(\
RNA
! "
#
$
%
! A
% B
&
'
( )
*
" + ,
- . /
0 /
1 2 3 4
!
% 5 '6 7 4 5
89 7 : (
;
* 8 3- 9
' 4 + < =>
%
! => 6 5
? ' + @. A4
%
5 5 / 5
89 B 5 &
( C D
* ' 8 3- ' E ' F
7' ,. ' G , 1 2
% 8 <A& G 4
H . IJ4 G 9
%
K ' L9 ME
8 <A&
5 9 " N
O P4 '
( Q
* 4
%
A '
%
<
%
%
#
% 3- 8 K
% 8
%
%
' AR I S 6
% A PI
%
A T ! 3 4
% '
9
% P@- G
%
A 6
UI. 1 @' 89 "
S (AFP Acute Flaccid Paralysis
* A V4 (
W
*
X? /: 9 ' S UI. ' E P . " . A 5 A ' " Y .
( N
*AFP 9
$ 7& ? ' N E>
' ( Z
*
N '
$ AFP
&
T A [P4 2 \ J ' 5 4
] 8 <A& . 5: ' 1 , ,R4 ^ T 5 G . 7 : ' A4
! ( _
*
5 ? ] R N ' $ / 9 & . > / 8 <A& / @J? . ' ! $:
89 9 '
N 7 B &
AFP
A ^ T
< & 89 4
& F ? / ?S + A S
89 2 4 ] R N ^ T (
_
*
!
8. ' S UI. ' ` ? N
a ] 9 b F 5 - ' / $
89 A / 3 9 ' ] R N $ MEH .
6
' / " 9 A 4
( c
* /
$: . Y . )dc
B. ^ ! 9 e
MEH . ' (
W
*
"
/ f > 1 ' ] R [ ' & 4 ' [ R A' ( )d
* X$ ' ] R N 9 " ' '
$: . Y . B.
' ( _
* Y "
N
N 3 1 -E> 4
b ! 1 8<9 " <4
8 <A&
( _
* 4 ' / g
5 9 h
( ))
*
$ b ! N A
/ = ? ?S
G . "
5 5 i. ? ' 5 1 T $ '
/
$ b !
?S (
);
* i. 5 & 7 j 4
5 9 5 9 7' L9 8 <H " kA ] => l6& 5 9 " 5 I' 87&
M R ? ?S $ ?
7& 8 7' 5 / 9 " k
A N ' E-
' ` ? N AFP
A / 3 9 ' ] R
7 ? MEH .
A ( )C
*
N K " / m
N ] R N
AFP
5 6A 1 @' 87& 5 I' 5 9 5 9
' + 3> UI. ? / 5 A>
" kA
, B. X$ " '
$
88 m 0
1!%
- 2"
4 m
= !"
4>9?
j
1 2 MEH . 7 : b ! X$ $
8. !
_ '
rI' :
% 2%
A ]
A ' 8 6 nA '
7' 1 / 5 / 8 7' 6 " $ o 8
+ 9 39 4 " . / ' / 7' )C_C
5 A ' /
' ` ? 5 9 9 9 AFP
;)
Y . A
BA&
: 5 6A ]'
_W A / MEH .
;
MEH . 3@4 G 9 Q
m > 9 5 9 A '
b ' 7'
grab sampling 47
! A4
A
^ MEH . ' O ' (
Raw sewage
* '
MEH . 8A /
( Influent
* BA&
:
A A4 GTS
5 6 S $ p MEH .
A Y . )d n 9E m q [9 4 ' ^ !
b
?r 6r 9 X? /: '
+ 3> UI.
(
*NPL
4 , ,R4 B
X?
5 74 n 6 ^ I- ,
! A4
A 1 @J?
8Ph A V 4 ?9
A 7X + ,
$ I9 8?r ' s ,I4 / P
7X 9 T / 8 -
D
&
9 ^ T !
: 2 [
% 2%
] A MEH .
G , 1 2 '
t Ii4 b ' ' 9
( Pellet
* . i4 b
( Two-phase
*
8. ! 9 '
m q '
8' h 1 2 ' 8- 9 ' A R
D 9 &
!
F ' B uv9
9 "$
8. + , b ' t Ii4 '
Pellet /
MEH . A ' ZQ
I ' $ Q
$ $ n 9E 9
)Q I
, $
Q
&
Qddd 1 ' RPM
)d w 3 9 , uv9
$ $
<' S 3 9 '
D
&
! 7X
b Two-phase 7 ? b / 3 9 '
x y
(
*Hovi + 9 5 nA
;dd)
^ T / 1 2 '
# Ddd I
IS MEH . B / $
"$ p %%% ' & + )
$
%J%
Wddd Cd PEG
2 ( 8 /
*Merk
;d 2
5 r
' ' O '
r
Leuconostoc mesenteroides
$ $ 5/ '
;dddddd (
sigma QCZW
*D FA
^ <>
( 8 /
*Merk Q 5 6 ' L 4 4 ' f W
z )CC
^ ! (
*W/V
;d
^ ! (
*W/V )W
I
$ (
*V/V ' . H 5:
! G V 4/ u { + IR pH
Z 4 _ 9 '
+ p
R "$
| .
1 '
' 8- 9 p
n ( Horizontal shaker
* '
;Wd RPM
} p ' "$ 1 R uv9
r &
( Separation funnel
* Ddd I
J $
L p (
Overnight
* D
7X &
!
<' IS Q
M 9 f / $ I
7
( bottom phase
* / . " ' n?4 { f
( Interphase
* BA&
$ $ / n ' :
Pellet
! . H P IS (
_
*
r ' 5 ' " ' / ' : IS
~ ' D
I / $ A / . ' 9 t Ii4 G ,
I p MEH .
•$ ^ . Ir $ (
8 /
*Merk
. H Y . A / ^ ! F , " kA
c
I . ' / $
" $ 9 1 3 .
F S PBS
I
! . H 5: ' ^ . I $
;d ,
;dd
$ $ n ' RPM uv9
)d
$ $ 1 R ,
;ddd Q RPM
&
M 4 r A 4 B w 3 9
BA& 9
! :
n P C' M2 C &HN # C &H O B" = =
m 8>
s :
$I /t
] /
$ I9
;dB L RD
Hep-2
$ / 9 & '
3 9 $ j
8 9 S ' $ I9
I 9
&
! " <4 X? /:
' F
/ C p A 4 A
MEH . A
Y . W
$ $
$ I9 8?r
;dB L RD Hep-2
. ! V 5 6
s ,I4 A ' 8?r $ $
$ I9
;dd s ,I4 / u ' $ n CW
' &
1 Z
! 7X /
'
? CPE
( Cytopathic effect
*
$ $ /
€ n9 n '
<
( Inverted Microscope
*
A 9 '
8P•
;d 0 7X &
!
" kA
/ u Z /
$ $
% 3
;d 0
&
6 .
u /
^ ! 5 r
| 4 ( Freeze & Thawing
*
w 9 T
A '
$ 8P• RD
;dB w 9 ' 3 L ' RD
;dB 1 2 L
8. ! : C ' I' [ % H[
]
$ I9 8? U " <4 / u
A '
' 2 @ 5 9 6 $ 4 8 4 8P•
: / 3 9 '
S 74 + I I
1
‚ 4 9 I- '
^ T 9 }I J
8 I / 8 4 " ^ T ' 4 n
( n
8 I
* 3 9
& '
/ :
^ 9 pooled polio : (PP)
^ 9 r r r
4 B1 ( B6
*CP O IJ - AT 83
:
O ' 9
r r r '
;d A9 Y
^ ' }I J r
4A 3 9 G
: ' 5 9 6 $ 4
^ 9 5 ? PP
: ' 5 • $
^ 9 4g CP r
r r r &
' B r
: - AT 9
( pooled
*
: "
I- ' }I J
ƒf A< 89
^ 9 : ' 5 9 6 $ 4 4 A
G
1 2
! + & / 3 9 ' G Y
A
„ 7& 8 7' 5 / 9
! " <4 A !
: / ^ nk ' $ A S
^ 9
•
5 ? ?
/ > IJ &
j &
‚ 4 ' (
*NTEV '
:
^ 9 89 8 r &
' " kA : / & $
^ 9
pooled polio (
*PP :
^ 9 O IJ
PI PII
PII PIII PI 3 9 PIII
( _
*
i : ' I' H[
] 8 r 2 @
$ 6
$ (
*RIVM
I ?
% 8 7' 5 / 9 [9 4 74
? /: 7&
% X + 3> UI.
! p 8 4 "
[9 4 r 8 I n
! IgG
$ H
‚ 4 )
; C
$ " < b 9 ' T
uv9
' 5 9 ' n :
^ 9 B> , M…& !
2 @
‚ 4 ( cross-absorbed
* '
u
? / :
^ 9
? @ !
IgG
5 ? ! H
/ r '
HRP
( A-horseradish perioxidase
* . H 4
:
^ 9
9 !
A p
A
:
+ 4 4 $ H ! '
( ' G r
" r
N r ?S ' G
* p
: B
?S $ H '
p
J " r $ H ' : C
p /
B r ^ r C
x M…&
( Optical density
*
X G ' '
89 V b 9 5 ? '
( )D
*
8T m 0
1!%
- 2"
4 m
= !"
4>9?
:
C ' =(= F H[
] / 8 4 "
?S " r ^ w & 1 .E
3 9
8A ' r L9 M
VP1/2A
9 " r 5 ?
| . '
" '
" r /
?S r ' / " kA
† {A& 4 ' j { S ' r X M Q
^ w
( NTR†
*5
A4 9
8q 3S
3 9 5 - ' 6 89
^ T '
/ f ' 4 ' 5 9 6 P M 8 4
$ ( r 89 ^ I< 5: ‚ 4
* ' &
b "
I . ' ‡ J 9 RNA
uv9 M
5 ? '
Digoxigenin (
*DIG ' 5:
6.
M
? S > ? '
M ‡
'
N r [9 4 G 6 :
0 ' 9 9
!
•J? r {n$ ˆ ? 1 2 ' 8P• N r
( )D
*
6. ^ ' : 89 ' U : 6 $ : J SPSS
)C
^ T ( SPSS Inc., Chicago, IL, USA
*
& = + 9 39 4 " . / )C_C
;)
/ Y . A
' ` ? 5 A ' _W AFP
MEH . / A
5 / G& ^ & ' / MEH . 3@4 G 9 Q
5 9 A '
# ' / " A$
- A & " 4 l P f G4
/ L$ ] ' "' I- 7' ‰ 6' 5 9 A ' 5
: 7'
b ' 7' 9 / <4 R]9
Grab Sample
! 74 B / 4 .
' A
( MEH .
*
' 5 n P ,4 N K S /
@. [9 > '
;) BA& MEH . A :
G , 1 2 '
t Ii4 b '
$ I9 L20B RD
Hep-2 / 9 &
!
‚ 4 9 " <4 ' uv9 }I J
$ j 8 4 $
%
$ 4
% 9 6
% 5
%
T 2 @
% ^ S
%I
<'
% . 87&
%
‚ 4 " ' | S
%
? NSL
( Non Sabin Like
*
"
( SL Sabin Like
*
8 4 / $
F w 6 $ F w :
! 3 9 5 9 6 P M / Y AT
;) BA& Y . A
5 A ' / :
' ` ?
<4 AFP Q
( _) z
;C 2
* A
' / <4 " /
; ( Q;
z c 2
*
/ $ A
C (
;c z )D 2
* A
/ 9 & $ j / " kA
_W
: BA& MEH . A /
Dc A ( c_
z QW
2
* /
DW ( Dc z QC 2
* )_
( cC z
;d 2
*
L 4 4 ' A
! / 9 & $ $ j
( + &
)
*
8 4 ^ T '
! •J? v 4 " ' | .
^ A4 A / & $
Y .
.
" ‚ 4 ' O ' MEH ' SL
/ 9 & . " ? '
$
G 9 ' O ' MEH . / $ j
. ' L 4 4 ' 5 / G& ^ & MEH . 3@4 Qc
z c
2 ( Z
* )_
z )c 2 ( )D
* '
/ " kA _)
z )Z 2 A /
‚ 4 $
; / _Q z W 2
‚ 4 $
C / 9 &
. " ? '
& $ j
' O ' 6 MEH . / E4
Cox-B E11
. ' L 4 4 ' NTEV dZ
z )Q 2 CC z );
2 cW z )d 2 Qc z c 2 ' / " kA
A Y .
‚ 4 $ ) C ' ^
5 6 ZW z D 2 / 9 &
Q;
z c 2 /
A Y .
ZW NTEV z D 2 S
n P C' M2 C &HN # C &H O B" = =
m 8?
'E14
^ T / u u 6 $ : 5 /:
: uv9
Post Hoc / 9 & " ' r ! •J?
G , b ' $
Two-phase . /
MEH
%
< mE
%
&
% (
dQ z d Š
*P kA
%
"
'
% , b "
% G Ii4 b
% t Pellet
Two-phase / 9 &
$ j
A /
< MEH . 8 &
( dQ z d Š
‹ P
A )
*
' 2%
4 ]
$%' '
= S K
$= I J = &%' I
r &u _ # -(" '(
v5#
+ 9 $
)c__
UI. 8 I $ T '
);Q / N ' f 9 5 7& ? CQdddd
'
8. ! '
$ " A
„ 7& 8 7' 5 / 9 '
4g P u 9 X? /: /
@@J4 9 9
'
+ 9 4 $ ? V '
;ddd A / j:
( )C )Q
*
K4 9 7 }I J ? ? ^ T '
I / ^E- ! & / 9 "A N
$ N / 9 "A
! 8 $ <. L$
! / 9 "A I2
' N
& 4 $ (
)W
* I- 8 ,. ^ - Gj
& ' 5 4 " ? 5 / 9 "
K4 9 "
/ F ? <4
);Q
?
0 ( 4 ] FH% S K $%' ' e=X [ H= \
$
<
(7
@
=
% 2% X' -(" '(
f ( P
C &HN # C &H C & ' P f (
= I
$= I J = &%'
= &%'
= I
$= I J = &%'
%'
= &
Fw % 2%
*
$6 % 2%
e2
1 2 ' -* (
2
*
<4
'(Q[
8h m 0
1!%
- 2"
4 m
= !"
4>9?
' a > Y W
+ 9 ?
;ddC . N
89 ( )Z
* Œ
9 V mE '
+
;ddD
;ddQ '
' F ? / $ 8I-
? <4 " / - ?
' ?S $ b !
))
N 6. ?
8.
8 A 5 ? $ "
T ? ' F ? / ?S $
7 : '
> /
F 5 - ' 5 5 i. ? .
a ] $ F w $ ` I'
( )_
*
" ' 1 T $ ' 5 I' 5 9 5 9
?S $ ] A ?
' 5 9 " N K " $ " A '
? 5 9 " 4 ] 5 -
8. ! 9 '
/ }I J ? ?S $ N
b 6! = >
1 2 ] R N AFP
! ( )c
*
N / 3 9 '
' ?S $ AFP
+ 9 : / 6 : 8 ,. 1 2
)ccD /
+ 9 ^ : M j
;ddd " ? (
Z
*
S B . ? ? ' " kA
G 9 X? /: MEH .
" ' 89 ^ T ] R N L9
+ 9 / $ b
;dd;
" ?
89 ( Z
*
^ - & ' • 9 ? / Ž<'
/ 9 &
A / ?S $
I
A 3 b !
b 6! MEH .
89 ( ))
* / 9 & Gj I- @
A / ?S
/ 9 & 5 6 I
A /
XA? N ] R
' 5 ?
N ] R N " ' ' AFP
4
•
? }I J S X
' (
;d
*
+ I9 + I9 L20B
v9 5w
5 ' $ ' + I9
(
;)
* /
+ 9 )cc_
+ I9
$ I9 " 6X & L20B
Hep-2 A ' $ I9 " 5 6A 3 9 !
X? /: P A4 RD 8 7' 5 / 9
„ 7&
89 + $ / 9 & '
Π/ 3 9
$ I9 L20B 5 'RD
Hep-2
/ 9 & 5 6 '
' $ j
\ @
! B
N < &
' H (
;;
*
$ I9 9 / N K " $ " A '
G 3 9
" 7' •J? : 89 ' U ' & 4 '
$ I9 5 $ / 9 & '
L20B
/ 9 & ' " 7'
! 4 4 ' B
5 L
$ I9 RD
Hep-2 89
x ( Poyry
*
+ 9 5 A
)c__
5 ?
‚ 4 $ )
XA 5 9 7 4
89 / 9 & ' MEH . /
‚ 4 $ S
; C
S "
; 4 C
' G 5 9 / u
/ 9 &
' (
;C
*
$ "
' 7 & 4 4
‚ 4 $ / 9 & ^ - )
N K "
' 7& 8 7' 5 / 9 [9 4 • " $ ' =' ]
. ! V M I] ] R N 8R2 4 2
S / Cd
2 A MEH .
BA&
b ' :
j Grab
$
! / 9 &
( _
*
b ' N K "
$ j 5 6 " / N ' t Ii4
n P C' M2 C &HN # C &H O B" = =
m 8x
8R2 A- 8 5 ? ! / 9 &
4 9 N K " ^ T ] R N
g
$ ?
'
?S $ N K " " kA
? / 9 & " / = ?
$ "
5 ? 4
K ' 5 / 9 "A N L9 s]9 4 " kA 9 ' ] ,]
g
' X
S L9 N ' ? AFP
? / ?S " . ! V '
9 ' , .:
/ "A 5 9 5 ' - ?
? 5 ,] Ž- ?
IA& / m > ? ' ? " /
& 5
^ A4 ' ' E- " ' '
' ' ] R N AFP
?S
( VDPV Vaccine-Derived Poliovirus
*
7 ? ? ' j M & ' j => '
!
$%' (g */[
' v9 L4 $ , " 5 !
8 AS $ AI- L] • & $
/ ' 5 74 n 6 ^ I- X? 7' 1 , ,R4
! : M & / " kA
6 89
A ' 8
^ R " $ o 8 7' 1 /
A A2 6 7' ' / 5 / 8 7' 6r 6X9 v9
!
References: __________________________________________________________
1. CDC. Enteroviruses-Respiratory and Enteric Viruses Branch: Viral ("Aseptic") Meningitis.
National Center of Infectious Diseases, 2005:
1-2. (at: http://www.cdc.gov/ncidod/dvrd/revb/
enterovirus/viral_meningitis.htm).
2. World Health Organization. Enteroviruses-Non Polio. WHO Media Center, 2005: 1-3. (at:
http://www.who.int/mediacentre/factsheets/fs174/
en/).
3. Fong TT, Lipp EK. Enteric viruses of humans and animals in aquatic environments: health risks, detection, and potential water quality assessment tools. Microbiol Mol Biol Rev 2005;
69: 357-71.
4. Wyn-Jones AP, Sellwood J. Enteric viruses in the aquatic environment. J Appl Microbiol 2001;
91:945-62.
5. Public Health Laboratory Network. Polio laboratory case definition, 2000: 1-7. (at:
http://www.health.gov.au/internet/wcms/Publishi ng.nsf/Content/cda-phlncd-
polio.htm/$FILE/polio.pdf).
6. Federal-Provincial-Territorial Committee on Drinking Water Guidelines for Canadian Drinking Water Quality: Supporting Documentation 2003: 1-24. (at:
http://www.health.gov.sk.ca/rr_water_sumofguid elines.pdf).
7. Melnick JL. Current status of poliovirus infections. Clin Microbiol Rev 1996; 9: 293-300.
8. World Health Organization. Guidelines for environmental surveillance of poliovirus circulation. Vaccines and Biologicals. WHO;
2003: 1-19. (at: http://www.who.int/vaccines- documents/DocsPDF03/www737.pdf).
9. Mas Lago P, Gary HE Jr, Perez LS, et al.
Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. Int J Epidemiol 2003; 32: 772-7.
10. van der Avoort HG, Reimerink JH, Ras A, et al.
Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands. Epidemiol Infect 1995; 114: 481-91.
11. Manor Y, Handsher R, Halmut T, et al.
Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J Clin Microbiol 1999; 37:1670-5.
12. CDC. Wild Poliovirus Transmission in Bordering Areas of Iran, Iraq, Syria, and Turkey, 1997-June MMWR 1998: 47; 588-92. (at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/0 0054164.htm).
13. World Health Organization. Global Polio Eradication Initiative Strategic plan 2004-2008.
Geneva, Switzerland, WHO Publication. 2003:
1-40. (at: http://whqlibdoc.who.int/hq/2004/
WHO_POLIO_04.02.pdf).
14. World Health Organization. Polio Laboratory Manual. Department of Vaccines and
89 m 0
1!%
- 2"
4 m
= !"
4>9?
Biologicals, Geneva, Switzerland, WHO Document Production Services, 2001; 1-133. (at:
http://www.who.int/vaccines/en/poliolab/WHO- Polio-Manual-9.pdf).
15. Deshpande JM, Shetty SJ, Siddiqui ZA.
Environmental surveillance system to track wild poliovirus transmission. Appl Environ Microbiol 2003; 69:2919-27.
16. Harris BN, Durrheim DN, Ogunbanjo GA.
Polio eradication--the validity of surveillance indicators. Trop Med Int Health 2003; 8: 386-91.
17. Blomqvist S, Savolainen C, Laine P, et al.
Characterization of a highly evolved vaccine- derived poliovirus type 3 isolated from sewage in Estonia. Journal of virology 2004; 78: 4876-83.
18. World Health Organization. Outbreak News. WER, 2004; 79: 273-80. (at: http://www.who.int /wer/2004/wer7930/en/index.html).
19. Patti AM, Santi AL, Fiore L, et al. Enterovirus
surveillance of Italian healthy children. Eur J Epidemiol 2000; 16:1035-8.
20. CDC. Progress towards poliomyelitis eradication-Egypt, 2003-2004. MMWR 2004;
53:820-2.
21. World Health Organization. Eradication Progress Brings Greater Laboratory Challenges.
Polio Lab Network 1998; 4: 1-4. (at:
http://www.who.int/immunization_monitoring/44 .pdf).
22. Distribution of L20B cells is underway. Polio Lab Network Quarterly Update. (at:
http://www.who.int/immunization_monitoring/In dex1995to2004.pdf)
23. Poyry T, Stenvik M, Hovi T. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol 1988; 54:371-4.
